| Novartis Pharma Schweiz AG - Azarga, Augentropfensuspension | | 59179 | | 01 | | Azarga | | Augentropfensuspension | | S01ED51 | | Timolol, Combinations | | 25.03.2009 | | |
| | Composition | | brinzolamidum 10 mg, timololum 5.0 mg ut timololi maleas, dinatrii edetas, natrii chloridum, mannitolum, tyloxapolum, carbomerum 974P, benzalkonii chloridum 0.1 mg, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml. | | Packungsbestandteile | | Augentropfensuspension | | | | | | | | Active Agent | Dose |
|---|
| Brinzolamide | 10 mg/ml | | Timolol | 5 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Brinzolamide | 10 mg | | Timolol | 5 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum | | | Aqua Purificata | | | Benzalkonium Chloride | 0.1 mg/ml | | Carbomerum 974P | | | Dinatrii Edetas | | | Mannitol | | | Sodium Chloride | | | Tyloxapolum | |
| |
| |
|
